Keskmine (tavaline)

Ravimiuuringud 2014

dr Kaire Aadamsoo  
  • An interventional , randomised, double-blind, parallel-group, placebo-controlled study on the efficacy of vortioxetine on cognitive dysfunction in patients with partial or full  remission  of major depressive disorder. Protokoll 15905A
  • An interventional, randomised, double-blind, parallel-group, placebo-controlled, active-referenced (paroxetine), fixed-dose study on the efficacy  of vortioxetine on  cognitive dysfunction  in working patients with major depressive disorder. Protokoll 15906A
dr Piret Aavik
  • Pharmacokinetics and safety of agomelatine in children (from 7 to less than 12 years) and adolescents (from 12 to less than 18 years) with Major Depressive Disorder. An open-labelled, multicenter, three-dose level, non-comparative study. Protokoll CL2-20098-075
dr Anu Ambos
  • An Open-label, Randomized, Multi-center, Parallel-Group Clinical Trial Comparing the Efficacy and Safety of Mylan’s Insulin Glargine with Lantus® in Type 1 Diabetes Mellitus atients. Protokoll MYL-GAI-3001
dr Julia Borissova
  • Phase III, randomized, double-blind, double-dummy, placebo-controlled, multicenter study to evaluate the efficacy (induction of remissioon) and safety of etrolizumab compared with adalimumab and placebo in patients with moderate to severe ulcerative colitis who are naive to TNF inhibitors. Protokoll GA28948
dr Anneli Elme
  • Evaluation of an immunomodulatory maintenance treatment in patients with metastatic colorectal  cancer  with tumor reduction during induction treatment. Protokoll MGN1703-C06
dr Ülo Kivistik
  • A Phase 3 Randomized Double-blind Study Comparing TR-701 FA and Linezolid in Ventilated Gram-positive Nosocomial Pneumonia. Protokoll TR701-132
dr Maire Kuddu
  • A phase III study of IV vinflunine in combination with methotrexate versus methotrexate alone in patients with recurrent or metastatic squamous cell carcinoma of the head and neck previously treated with platinum-based chemotherapy. Protokoll L00070 IN 309 FO
dr Kersti Kukk
  • A single arm, open label, multicentre extension study of bevacizumab in patients with solid tumours on study treatment with bevacizumab, at the end of a F. Hoffmann-La Roche and/or Genentech sponsored study. Protokoll MO25757
dr Edward Laane
  • A multicenter, open-label, single-arm, phase IIIb, international study evaluating the safety of Obinutuzumab alone or in combination with chemotherapy in patients with previously untreated or relapsed/refractory Chronic Lymphocytic Leukemia. Protokoll MO28543
dr Mari Meren
  • A prospective, multicenter, 12-week, randomized open-label study to evaluate the efficacy and safety of glycopyrronium (50 micrograms o.d.) or indacaterol maleate and glycopyrronium bromide fixed-dose combination (110/50 micrograms o.d.) regarding symptoms and health status in patients with moderate chronic obstructive pulmonary disease (COPD) switching from treatment with any standard COPD regimen. Protokoll CQVA149A3401
dr Pille Mukk
  • A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Two Dose Regimens (60 mg/kg and 120 mg/kg) of Weekly Intravenous Alpha1-Proteinase Inhibitor (Human) in Subjects with Pulmonary Emphysema due to Alpha1-Antitrypsin Deficiency. Protokoll GTi1201
  • Mepolizumab vs Placebo as add-on treatment for frequently exacerbating COPD patients. Protokoll MEA117106  
  • A Randomized, Double Dummy, Parallel Group Multicentre Trial Comparing the Efficacy and safety of UMEC/VI (A Fixed Combination  OF Umeclidinium and Vilanterol) With Tiotropium In Subjects with COPD Who Continue To Have Symptoms on Tiotropium. Protokoll DB2116960
dr Ene Ojassalu
  • An Open-label, Randomized, Parallel Group Study Assessing the Immunogenicity and Safety of Sarilumab Administered as Monotherapy in Patients with Active Rheumatoid Arthritis. Protokoll EFC13752
dr Anneli Parksepp
  • Interventional, open-label, long-term extension study to evaluate the safety and tolerability of brexpiprazole as adjunctive treatment in patients with major depressive disorder. Protokoll 14767B
dr Julia Reinmets
  • A Clinical Outcomes Study to Compare the Incidence of Major Adverse  Cardiovascular Events in Subjects Presenting with Acute Coronary Syndrome Treated with Losmapimod Compared to Placebo. Protokoll PM1116197
dr Mart Riispere
  • A Phase II/III Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172 and MK-8742 in Subjects with Chronic Hepatitis C Virus Infektion and Chronic Kidney Disease. Protokoll MK-5172-052-00
dr Jüri Teras
  • A Phase 3b, Double-Blind, Multicenter, Randomized Study to Compare the Efficacy and Safety of Single Dose Dalbavancin to a Two Dose Regimen of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections. Protokoll DUR001-303